How Electrical Storms Recur Over Time in Patients With Implantable Cardioverter Defibrillators - Subanalysis of the Nippon Storm Study -

被引:0
|
作者
Yasuoka, Ryobun [1 ]
Maruyama, Masahiro [1 ]
Nakazawa, Gaku [1 ]
Noda, Takashi [2 ]
Nitta, Takashi [3 ]
Aizawa, Yoshifusa [4 ]
Ohe, Tohru [5 ]
Kurita, Takashi [1 ]
机构
[1] Kindai Univ Hosp, Div Cardiol, 377-2 Ohno Higashi, Osaka 5898511, Japan
[2] Tohoku Univ, Grad Sch Med, Div Cardiol, Sendai, Japan
[3] Hanyu Gen Hosp, Saitama, Japan
[4] Tachikawa Med Ctr, Dept Res & Dev, Niigata, Japan
[5] Okayama City Hosp, Okayama, Japan
关键词
Electrical storm; Implantable cardioverter defibrillator; Primary prevention; Recurrent event analysis; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR-TACHYCARDIA; CATHETER ABLATION; MANAGEMENT; DEATH; TERM; PHARMACOTHERAPY; PREVENTION; PREDICTORS; GUIDELINE;
D O I
10.1253/circj.CJ-24-0390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Electrical storms (E-storms), defined as multiple fatal ventricular arrhythmias over a short period, negatively affect the prognosis of patients receiving an implantable cardioverter defibrillator or cardiac resynchronization therapy with a defibrillator (ICD/ CRT-D). However, the prognostic impact of recurrent E-storms has not been well elucidated. Methods and Results: We analyzed the association between E-storm recurrences and mortality using data from 1,274 participants in the Nippon Storm Study, a prospective observational study conducted at 48 ICD/CRT-D centers in Japan. Differences in E-storm recurrences by patient characteristics were evaluated using the mean cumulative function (MCF), which is the cumulative number of E-storm episodes per patient as a function of time. Patients with multiple E-storms had a 3.39-fold higher mortality risk than those without E-storms (95% confidence interval 1.82-6.28; P<0.01). However, there was no significant difference in mortality risk between patients with a single E-storm and those without E-storms. The MCF curve exhibited a slower ascent in patients who received primary prevention ICD/CRT-D than in those who received secondary prevention ICD/CRT-D. However, when analyzing only patients with E-storms, the MCF curves demonstrated comparable trajectories in both groups. Conclusions: E-storm recurrences may have a negative impact on prognosis. Once patients with primary prevention experience an E-storm episode, they face a similar risk of subsequent recurrent E-storms as patients with secondary prevention.
引用
收藏
页码:214 / 223
页数:10
相关论文
共 50 条
  • [31] Arrhythmic electrical storm: an important problem in patients with an implantable cardioverter defibrillator
    Topaloglu, Serkan
    Aras, Dursun
    Ozeke, Ozcan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2006, 34 (02): : 126 - 130
  • [32] Reduction of Inappropriate Shocks Over Time in Hypertrophic Cardiomyopathy Patients With Subcutaneous Implantable Cardioverter-Defibrillators
    Narayanan, Chockalingam
    Gionfriddo, William
    Shrestha, Srijan
    Koethe, Benjamin
    Katcher, Benjamin
    Garlitski, Ann
    Weinstock, Jonathan
    Homoud, Munther
    Maron, Barry
    Maron, Martin S.
    Rowin, Ethan J.
    Madias, Christopher
    CIRCULATION, 2021, 144
  • [33] Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator
    Arya, A
    Haghjoo, M
    Dehghani, MR
    Fazelifar, AF
    Nikoo, MH
    Bagherzadeh, A
    Sadr-Ameli, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03): : 389 - 392
  • [34] Antitachycardia pacing in patients with implantable cardioverter defibrillators: How many attempts are useful?
    Fries, R
    Heisel, A
    Kalweit, G
    Jung, J
    Schieffer, H
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (01): : 198 - 202
  • [35] Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators
    Stanislaw Morawski
    Patrycja Pruszkowska
    Beata Sredniawa
    Radoslaw Lenarczyk
    Zbigniew Kalarus
    Journal of Interventional Cardiac Electrophysiology, 2017, 50 : 227 - 234
  • [36] Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators
    Morawski, Stanislaw
    Pruszkowska, Patrycja
    Sredniawa, Beata
    Lenarczyk, Radoslaw
    Kalarus, Zbigniew
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2017, 50 (03) : 227 - 234
  • [37] Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study
    Alhakak, A.
    Ostergaard, L.
    Butt, J. H.
    Vinther, M.
    Philbert, B. T.
    Jacobsen, P. K.
    Petersen, J. K.
    Gislason, G. H.
    Torp-Pedersen, C.
    Kober, L.
    Fosbol, E.
    Mogensen, U. M.
    Weeke, P. E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 791 - 791
  • [38] Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients
    Vandenberk, Bert
    Garweg, Christophe
    Voros, Gabor
    Flore, Vincent
    Marynissen, Thomas
    Sticherling, Christian
    Zabel, Markus
    Ector, Joris
    Willems, Rik
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2016, 39 (08): : 848 - 857
  • [39] Longitudinal Study of Implantable Cardioverter-Defibrillators Methods and Clinical Characteristics of Patients Receiving Implantable Cardioverter-Defibrillators for Primary Prevention in Contemporary Practice
    Masoudi, Frederick A.
    Go, Alan S.
    Magid, David J.
    Cassidy-Bushrow, Andrea E.
    Doris, Jonathan M.
    Fiocchi, Frances
    Garcia-Montilla, Romel
    Glenn, Karen A.
    Goldberg, Robert J.
    Gupta, Nigel
    Gurwitz, Jerry H.
    Hammill, Stephen C.
    Hayes, John J.
    Jackson, Nathaniel
    Kadish, Alan
    Lauer, Michael
    Miller, Aaron W.
    Multerer, Deborah
    Peterson, Pamela N.
    Reifler, Liza M.
    Reynolds, Kristi
    Saczynski, Jane S.
    Schuger, Claudio
    Sharma, Param P.
    Smith, David H.
    Suits, Mary
    Sung, Sue Hee
    Varosy, Paul D.
    Vidaillet, Humberto J.
    Greenlee, Robert T.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (06): : E78 - E85
  • [40] Implantable cardioverter defibrillators at the end of life: How much do patients want to know?
    Raphael, C. E.
    Stain, N.
    Wright, I.
    Koa-Wing, M.
    Kanagaratnam, P.
    Francis, D. P.
    EUROPEAN HEART JOURNAL, 2009, 30 : 418 - 419